Sei Investments CO Opti Nose, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$6.4 - $10.94 $35,315 - $60,366	-5,518 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$6.1 - $10.3 $112,734 - $190,354	-18,481 Reduced 77.01%	5,518 $54,000
Q4 2018 Feb 13, 2019	BUY	$5.84 - $11.92 $139,967 - $285,686	23,967 Added 74896.88%	23,999 $148,000
Q3 2018 Nov 08, 2018	BUY	$12.43 - $29.76 $397 - $952	32 New	32 $0

85.2M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $56.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.